Author: Samantha Budd
OKYO Pharma Achieves 90% Enrollment in 240-Patient Phase 2 Clinical Trial of OK-101 to treat Dry Eye Disease (“DED”
Full enrollment anticipated by first week of September OKYO on schedule to release top-line data before end of 2023 Phase 2 trial is designed as potential registration trial with pre-specified primary efficacy endpoints covering...
Read MoreINVU Bold Women’s Fashion at SILMO 2023
Oversized square shaped women’s sunglasses with wide temples have iconic status in the fashion world and are undoubtedly one of the main trends for the upcoming 2024 season. The INVU designers refined this legendary shape from...
Read More
Elevate Your Elegance with Evatik
PRESENTS Fall introduces a season of infinite layering, allowing individuals to creatively piece...
Read More
